Huk W J, Gademann G
Neurosurg Rev. 1984;7(4):259-80. doi: 10.1007/BF01892907.
Magnetic resonance imaging (MRI) has undergone a rapid development which is still continuing. In this article a survey is given of the present status of this new diagnostic tool in the evaluation of diseases of the central nervous system. When atoms with uneven numbers of protons or neutrons in a homogeneous magnetic field are tilted against the main vector of this field by a radiofrequency pulse, nuclear magnetic resonance can be observed. During the relaxation of the little dipoles back to the direction of the underlying magnetic field, a resonance signal is generated. The superposition of variable field gradients enables the scanning of sectional images in the axial, frontal and sagittal plane. The variables of H+-magnetic resonance which can be utilized for imaging are: the proton density, the relaxation times T1 (spin-lattice) and T2 (spin-spin) and flow effects. While the proton density in organic tissue fluctuates only by some 10%, the relaxation times may vary by several hundred per cent. Tissue contrast, therefore, is mainly based on relaxation times differences. The image character can also be influenced by variations of imaging parameters (i.e. repetition rate, interpulse delay, read out or echo delay) in different imaging sequences, such as the spin-echo and the inversion recovery technique. Depending on these imaging parameters T1 and T2 will contribute to the signal to a varying degree. This fact is most important for the diagnostic information of MRI. In initial clinical experiences in the diagnosis of diseases of the central nervous system, MRI has demonstrated high sensitivity in the detection of lesions (such as oedema, neoplasms, demyelinating disease), but less significance in lesion discrimination. In spinal disease the direct sagittal imaging of MRI enables MRI-myelography without contrast medium, superior to conventional myelography in many cases. For detailed evaluation of disc disease, however, the spatial resolution still has to be improved. Promising results have been obtained from flow effects. Depending on the flow velocity of blood, vessels appear white with intensive signals (slow flow) or black due to low signal intensities (rapid flow). MRI-angiography including measurement of blood flow seems possible. MRI-contrast media are not yet available for routine clinical use. Promising results have been reported on the basis of rare-earth elements, such as gadolinium Gd3+. These substances decrease T1 and T2 with subsequent increase in signal intensity. Concerning harmful side-effects of MRI, three possible sources have to be considered: the static magnetic field, the changing magnetic field, and radiofrequency heating.(ABSTRACT TRUNCATED AT 400 WORDS)
磁共振成像(MRI)发展迅速,且仍在持续发展。本文综述了这种新型诊断工具在评估中枢神经系统疾病方面的现状。当在均匀磁场中质子数或中子数为奇数的原子被射频脉冲倾斜至与该磁场的主矢量相反方向时,就能观察到核磁共振现象。在小磁偶极子弛豫回到基础磁场方向的过程中,会产生一个共振信号。可变场梯度的叠加使得能够在轴向、额面和矢状面扫描断层图像。可用于成像的氢质子磁共振变量有:质子密度、弛豫时间T1(自旋晶格)和T2(自旋自旋)以及血流效应。虽然有机组织中的质子密度仅波动约10%,但弛豫时间可能会有几百%的变化。因此,组织对比度主要基于弛豫时间的差异。图像特征也可能受到不同成像序列(如自旋回波和反转恢复技术)中成像参数(即重复率、脉冲间隔延迟、读出或回波延迟)变化的影响。根据这些成像参数,T1和T2对信号的贡献程度会有所不同。这一事实对MRI的诊断信息极为重要。在中枢神经系统疾病诊断的初步临床经验中,MRI在检测病变(如水肿、肿瘤、脱髓鞘疾病)方面显示出高敏感性,但在病变鉴别方面意义较小。在脊柱疾病中,MRI的直接矢状面成像可实现无需造影剂的磁共振脊髓造影,在许多情况下优于传统脊髓造影。然而,对于椎间盘疾病的详细评估,空间分辨率仍有待提高。血流效应已取得了有前景的结果。根据血流速度,血管在信号强时呈白色(血流缓慢),或因信号强度低而呈黑色(血流快速)。包括血流测量在内的磁共振血管造影似乎是可行的。磁共振造影剂尚未用于常规临床应用。基于稀土元素(如钆Gd3+)已报道了有前景的结果。这些物质会降低T1和T2,随后增加信号强度。关于MRI的有害副作用,必须考虑三个可能的来源:静磁场、变化的磁场和射频加热。(摘要截选至400字)